Scroll to top

Archive

CLINUVEL
Posted by CLINUVEL
November 26, 2019

CLINUVEL Appoints Non-Executive Director

CLINUVEL PHARMACEUTICALS LTD today announced the appointment of Professor Jeffrey Rosenfeld as...

Read More
CLINUVEL
Posted by CLINUVEL
November 20, 2019

Chair’s Address to the Annual General Meeting

Melbourne, Australia, 20 November 2019 A MOMENTOUS ACHIEVEMENT Looking at the year...

Read More
CLINUVEL
Posted by CLINUVEL
November 20, 2019

Results of Meeting

  Results of Annual General Meeting In accordance with Listing Rule 3.13.2...

Read More
CLINUVEL
Posted by CLINUVEL
November 20, 2019

Managing Director's AGM Presentation

Melbourne, Australia, 20 November 2019 “We are here today to reflect on...

Read More
CLINUVEL
Posted by CLINUVEL
October 31, 2019

Appendix 4C

CLINUVEL PHARMACEUTICALS LTD, a global biopharmaceutical company focused on developing and delivering...

Read More
CLINUVEL
Posted by CLINUVEL
October 30, 2019

TGA Priority Registration Pathway for SCENESSE

CLINUVEL PHARMACEUTICALS LTD today announced that the Australian Therapeutic Goods Administration (TGA)...

Read More
CLINUVEL
Posted by CLINUVEL
October 30, 2019

Letter from the Remuneration Committee Chair

Dearest Shareholders, As the incoming Chair of the Company, in short letters...

Read More
CLINUVEL
Posted by CLINUVEL
October 18, 2019

CLINUVEL Chair to Retire Following FDA Approval

CLINUVEL PHARMACEUTICALS LTD today announced that Mr Stan McLiesh will retire from...

Read More
CLINUVEL
Posted by CLINUVEL
October 18, 2019

Appendix 4G and Corporate Governance Statement

  CLINUVEL PHARMACEUTICALS Corporate Governance Statement has been updated and is available...

Read More
CLINUVEL
Posted by CLINUVEL
October 18, 2019

Annual Report to shareholders

  CLINUVEL’s Annual Report for the year ended 30 June 2019. Download...

Read More
CLINUVEL
Posted by CLINUVEL
October 18, 2019

Notice of Annual General Meeting/Proxy Form

  This Explanatory Memorandum has been prepared for the Shareholders of the...

Read More
CLINUVEL
Posted by CLINUVEL
October 17, 2019

CLINUVEL Newsletter

  In this News Communiqué VII, we pause to reflect on the...

Read More
CLINUVEL
Posted by CLINUVEL
October 15, 2019

Chair Letter to Shareholders

  Dear All, In my career in life sciences, I have served...

Read More
CLINUVEL
Posted by CLINUVEL
October 10, 2019

Audio Transcript Investor Teleconference

  An audio transcript of the investor teleconference held yesterday can be...

Read More
CLINUVEL
Posted by CLINUVEL
October 9, 2019

FDA Grants Marketing Approval For SCENESSE

  It is a privilege for CLINUVEL PHARMACEUTICALS LTD to announce the...

Read More
CLINUVEL
Posted by CLINUVEL
October 8, 2019

Trading Halt

  The securities of Clinuvel Pharmaceuticals Limited (CUV) will be placed in...

Read More
We use cookies to give you the best experience.